Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

15 Sep 2015 Evaluate

Glenmark Pharmaceuticals has informed regarding a Press Release dated September 15, 2015 titled ‘Glenmarks Bi-Specific Antibody - GBR 1302 to enter Phase I trials’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1335.00
Cipla 1358.00
Lupin 1984.70
Zydus Lifesciences 1187.00
View more..